JEAP 2026 Opens applications for regenerative medicine companies
Applications open to JEAP 2026 to accelerate regenerative medicine companies’ growth in Japan
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.